A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1515-1521

  Cao, Wen M ^a   Murao, Koji ^a   Imachi, Hitomi ^a   Yu, Xiao ^a   Abe, Hiroshi ^a   Yamauchi, Akira ^a   Niimi, Michio ^a   Miyauchi, Akira ^b   Wong, Norman C W ^c   Ishida, Toshihiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KUMA HOSPITAL   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN RECEPTOR; HUMAN HOMOLOG OF SCAVENGER RECEPTOR TYPE BI; LIMPII ANALOGOUS 1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR B; THYMIDINE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; WORTMANNIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD36; APOPTOSIS; BREAST NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; FEMALE; HUMANS; LIPOPROTEINS, HDL; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RNA-BINDING PROTEINS; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTION FACTOR AP-1;

EID: 10744223205     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0675     Document Type: Article

References (33)

1. Boyd, N. F., and McGuire, V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J. Natl. Cancer Inst. (Bethesda), 82: 460-468, 1990.
2. Gospodarowicz, D., Lui, G. M., and Gonzalez, R. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium. Cancer Res., 42: 3704-3713, 1982.
3. Johnson, W. J., Mahlberg, F. H., Rothblat, G. H., and Phillips, M. C. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta, 1085: 273-298, 1991.
4. Rotheneder, M., and Kostner, G. M. Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines. Int. J. Cancer, 43: 875-879, 1989.
5. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science (Wash. DC), 271: 518-520, 1996.
6. Calvo, D., and Vega, M. A. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J. Biol. Chem., 268: 18929-18935, 1993.
7. Murao, K., Terpstra, V., Green, S. R., Kondratenko, N., Steinberg, D., and Quehenberger, O. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem., 272: 17551-17557, 1997.
8. Imachi, H., Murao, K., Sato, M., Hosokawa, H., Ishida, T., and Takahara, J. CD36 LIMPII analogous-1, a human homolog of the rodent scavenger receptor BI, provides the cholesterol ester for steroidogenesis in adrenocortical cells. Metabolism, 48: 627-630, 1999.
9. Imachi, H., Murao, K., Hiramine, C., Sayo, Y., Sato, M., Hosokawa, H., Ishida, T., Kodarna, T., Quehenberger, O., Steinberg, D., and Takahara, J. Human scavenger receptor BI is involved in recognition of apoptotic thymocytes by thymic nurse cells. Lab. Investig., 80: 263-270, 2000.
10. Imachi, H., Murao. K., Sayo, Y., Hosokawa, H., Sato, M., Niimi, M., Kobayashi, S., Miyauchi, A., Ishida, T., and Takahara, J. Evidence for a potential role for HDL as an important source of cholesterol in human adrenocortical tumors via the CLA-1 pathway. Endocr. J., 46: 27-34, 1999.
11. Imachi, H., Murao, K., Cao, W. M., Ohyama, T., Sato, M., Sasaguri, Y., Ishida, T., and Takahara, J. Expression of HDL receptor, CLA-1 in human smooth-muscle cells and effect of interferon-γ on its regulation. Horm. Metab. Res., 33: 389-393, 2001.
12. Imachi, H., Murao, K., Cao, W., Tada, S., Taminato, T., Wong, N. C., Takahara, J., and Ishida, T. Expression of human scavenger receptor b1 on and in human platelets. Arterioscler. Thromb. Vasc. Biol., 23: 898-904, 2003.
13. Pussinen, P. J., Karten, B., Wintersperger, A., Reicher, H., McLean, M., Malle, E., and Sattler, W. The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous1)-mediated selective cholesteryl ester uptake. Biochem. J., 349: 559-566, 2000.
14. Suc, I., Escargueil-Blanc, I., Troly, M., Salvayre, R., and Negre-Salvayre, A. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol., 17: 2158-2166, 1997.
15. Cao, W. M., Murao, K., Imachi, H., Sato, M., Nakano, T., Kodama, T., Sasaguri, Y., Wong, N. C., Takahara, J., and Ishida, T. Phosphatidylinositol 3-OH kinase-Akt/ protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell line. Arterioscler. Thromb. Vasc. Biol., 21: 1592-1597, 2001.
16. Connelly, M. A., de la Llera-Moya, M., Monzo, P., Yancey, P. G., Drazul, D., Stoudt, G., Fournier, N., Klein, S. M., Rothblat, G. H., and Williams, D. L. Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain. Biochemistry, 40: 5249-5259, 2001.
17. Connelly, M. A., Kellner-Weibel, G., Rothblat, G. H., and Williams, D. L. SR-BI-directed HDL-cholesteryl ester hydrolysis. J. Lipid Res., 40: 331-341, 2003.
18. Murao, K., Wada, Y., Nakamura, T., Taylor, A. H., Mooradian, A. D., and Wong, N. C. Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J. Biol. Chem., 273: 18959-18965, 1998.
19. Sayo, Y., Murao, K., Imachi, H., Cao, W. M., Sato, M., Dobashi, H., Wong, N. C. W., and Ishida, T. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology, 143: 2437-2440, 2002.
20. Pittman, R. C., Knecht, T. P., Rosenbaum, M. S., and Taylor, C. A., Jr. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem., 262: 2443-2450, 1987.
21. Liu, Y., Ludes-Meyers, J., Zhang, Y., Munoz-Medellin, D., Kim, H. T., Lu, C., Ge, G., Schiff, R., Osborne, C. K., and Brown, P. H. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene, 21: 7680-7689, 2002.
22. Schiff, R., Reddy, P., Ahotupa, M., Coronado-Heinsohn, E., Grim, M., Hilsenbeck, S. G., Lawrence, R., Deneke, S., Herrera, R., Chamness, G. C., Fuqua, S. A., Brown, P. H., and Osborne, C. K. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J. Natl. Cancer Inst. (Bethesda), 92: 1926-1934, 2000.
23. Imbra, R. J., and Karin, M. Metallothionein gene expression is regulated by serum factors and activators of protein kinase C. Mol. Cell. Biol., 7: 1358-1363, 1987.
24. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (Lond.), 407: 538-541, 2000.
25. Sun, M., Paciga, J. E., Feldman, R. I., Yuan, Z., Coppola, D., Lu, Y. Y., Shelley, S. A., Nicosia, S. V., and Cheng, J. Q. Phosphatidylinositol-3-OH Kinase(PI3K)/ AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res., 61: 5985-5991, 2001.
26. Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M., de Falco, A., Lombardi, M., Florentino, R., Varricchio, L., Barone, M. V., and Auricchio, F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J., 20: 6050-6059, 2001.
27. Clark, A. S., West, K., Streicher, S., and Dennis, P. A. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther., 1: 707-717, 2002.
28. Perez-Tenorio, G., and Stal, O. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br. J. Cancer, 86: 540-545, 2002.
29. Dimmeler, S., Haendeler, J., Galle, J., and Zeiher, A. M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the "response to injury" hypothesis. Circulation, 95: 1760-1763, 1997.
30. Gu, X., Trigatti, B., Xu, S., Acton, S., Babitt, J., and Krieger, M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem., 273: 26338-26348, 1998.
31. Gu, X., Lawrence, R., and Krieger, M. Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection. J. Biol. Chem., 275: 9120-9130, 2000.
32. Yuhanna, L. S., Zhu, Y., Cox, B. E., Hahner, L. D., Osborne-Lawrence, S., Lu, P., Marcel, Y. L., Anderson, R. G., Mendelsohn, M. E., Hobbs, H. H., and Shaul, P. W. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med., 7: 853-857, 2001.
33. Silver, D. L. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J. Biol. Chem., 277: 34042-34047, 2002.